Recombinant Human Insulin-like Growth Factor 2 (somatomedin A)
Cat.No. : | IGF2-609H |
Product Overview : | Recombinant humanIGF2 protein was expressed in E. coli. They are made by reacting hIGF-II withSulfo-NHS-Biotin reagent. In di-biotinyl-human-IGF-II both the a-amino groupof the N-terminal alanine and the e-amino group of the lysine at position 65are biotinylated. |
- Specification
- Gene Information
- Related Products
Cat. No. : | IGF2-609H |
Description : | IGF2 is one ofthree protein hormones that share structural similarity to insulin. IGF2 iscreated by Theca cells to act in an autocrine manner on the theca cellsthemselves, and in a paracrine manner on Granulosa cells in the ovary. IGF2promotes granulosa cell proliferation during the follicular phase of themenstrual cycle, acting alongside Follicle Stimulating Hormone. |
Source : | Following thereaction of hIGF-II with Sulfo-NHS-Biotin reagent , the mono- anddi-biotinyl-human-IGF-II are separated from the other reaction products byHPLC. The mono-biotinyl-human-IGF-II and the di-biotinyl-human-IGF-II peaksare then further purified by HPLC to yield Receptor Grade products. |
Species : | Human |
Purity : | Greater than 95 %(by HPLC) |
Molecular Weight : | Mono-biotinyl-human-IGF-II-7696daltons; Di-biotinyl-human-IGF-II-7922 daltons; Homogeneity and mass of bothconfirmed by Mass Spectrometry. |
N-terminal sequence analysis : | 5 residues Greaterthan 95 % single sequence. |
Biological Activity : | Western ligand blotto bovine IGFBP-2. |
Endotoxin : | Less than 0.1 EU/μg |
State and appearance : | Lyophilized whitepowder. Dried from 0.1 M acetonitrile/ 0.1% trifluoroacetic acid and storedunder dry nitrogen at a slight vacuum (-25 kPa). |
Reconstitution : | Handling of GroPepIGF-I, IGF-II and IGF Analogs. |
Storage : | At least 2 years at2 - 4°C (lyophilized). |
OfficialSymbol : | IGF2 |
Pathways : | Apoptosis; Diabetespathways; Endochondral Ossification; Hedgehog Signaling Pathway; Regulationof Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth FactorBinding Proteins (IGFBPs) |
Gene Name : | IGF2 insulin-like growth factor2 (somatomedin A) [ Homo sapiens ] |
Synonyms : | IGF2;insulin-like growth factor 2 (somatomedin A); IGF-II; PP9974; C11orf43;FLJ22066; FLJ44734; insulin-like growth factor II;somatomedin-A; OTTHUMP00000011012; OTTHUMP00000011013; OTTHUMP00000011015;OTTHUMP00000011018; OTTHUMP00000011157; OTTHUMP00000011158;OTTHUMP00000220677; insulin-like growth factor type 2; chromosome11 open reading frame 43; Insulin-like growth factor II; Somatomedin-A |
Gene ID : | 3481 |
mRNA Refseq : | NM_001127598 |
Protein Refseq : | NP_001121070 |
MIM : | 147470 |
UniProt ID : | P01344 |
Chromosome Location : | 11p15.5 |
Function : | growth factoractivity; hormone activity; insulin receptor binding; insulin-like growthfactor receptor binding; protein binding; protein serine/threonine kinaseactivator activity; receptor activator activity |
Products Types
◆ Recombinant Protein | ||
IGF2-559H | Recombinant Human IGF2 Protein, Fc-tagged | +Inquiry |
IGF2-5430H | Recombinant Human Insulin-Like Growth Factor 2 (somatomedin A) | +Inquiry |
IGF2-054H | Recombinant Human IGF2 Protein | +Inquiry |
IGF2-123M | Active Recombinant Mouse IGF2 Protein | +Inquiry |
IGF2-2279H | Recombinant Human IGF2 Protein, His-tagged | +Inquiry |
◆ Native Protein | ||
IGF2-29116TH | Native Human IGF2 | +Inquiry |
IGF2-621H | Native Human Insulin-Like Growth Factor 2 (somatomedin A) | +Inquiry |
◆ Lysates | ||
IGF2-5266HCL | Recombinant Human IGF2 293 Cell Lysate | +Inquiry |
Related Gene
For Research Use Only. Not intended for any clinical use. No products from Creative BioMart may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative BioMart.
Inquiry
- Q&As
- Reviews
Q&As (5)
Ask a questionYes, IGF2 levels may serve as predictive markers for certain diseases. Monitoring its expression could help identify individuals at risk or track disease progression.
Researchers are exploring various approaches, including drug development, to modulate IGF2 levels for therapeutic purposes. This may involve targeting its receptors or modifying its expression.
IGF2 has been linked to the aging process and age-related diseases. Exploring its role may provide insights into slowing down aging or managing age-related conditions.
Research is exploring the potential use of IGF2 in regenerative medicine due to its role in cell growth and tissue repair. It may offer new avenues for tissue regeneration.
Yes, there are ongoing clinical trials investigating the use of IGF2 in various conditions. These trials aim to assess its safety and efficacy in a clinical setting.
Customer Reviews (3)
Write a reviewThe IGF2 protein is an exceptional choice that meets the highest standards of quality, making it perfectly suited for your experimental needs.
The IGF2 protein is of the highest quality and perfectly suited for your experimental requirements.
In addition to its exceptional quality, the IGF2 protein is backed by excellent technical support offered by the manufacturer.
Ask a Question for All IGF2 Products
Required fields are marked with *
My Review for All IGF2 Products
Required fields are marked with *
Inquiry Basket